Brochure More information from http://www.researchandmarkets.com/reports/2669726/

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Description:

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India Summary We have released our latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape India". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by Our team of industry experts. India is the second most populated country in the world with a population of approximately 1.24 billion in 2014. The country’s pharmaceutical market was estimated at $24.2 billion in 2014 and is expected to reach approximately $60.5 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 16.5%. The value of the Indian medical device market was $6.6 billion in 2008, and is expected to register a CAGR of 7.7% to reach an estimated $10.3 billion in 2020. The main growth factors are - Increasing coverage of healthcare insurance - Improving access to medical facilities in both urban and rural areas - Government initiatives for easy access to healthcare facilities Scope The report provides information on the healthcare, regulatory, and reimbursement landscape in India, and includes - An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers - Profiles and SWOT analyses of the major players in the pharmaceutical market: Dr Reddy’s, Lupin, Cipla, Aurobindo and Cadila; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Johnson & Johnson, DePuy, Roche and Philips - Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices - Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure - An overview of the opportunities for and challenges to growth in the healthcare market Reasons to buy This report will enhance your decision-making capability by allowing you to - Develop business strategies by understanding the trends shaping and driving India’s healthcare market - Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect India’s healthcare market in the future - Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships - Identify, understand, and capitalize on the opportunities and challenges in India’s healthcare market

Contents:

1.1 List of Tables 1.2 List of Figures

2 Introduction 2.1 Report Guidance 3 Overview of the Pharmaceutical and Medical Device Markets 3.1 Pharmaceutical Market 3.1.1 Market Overview 3.1.2 Pharmaceutical Exports and Imports 3.1.3 Supply Channels 3.1.4 Market Segments 3.1.5 Major Therapeutic Areas 3.1.6 Major Players 3.2 Medical Device Market 3.2.1 Market Overview 3.2.2 Overview of Top Five Segments 3.2.3 Diagnostic market 3.2.4 Major Players 3.3 Market Drivers and Barriers 3.3.1 Drivers 3.3.2 Barriers 4 Market Access 4.1 Reimbursement and Payer Landscape 4.1.1 Overview of Healthcare System 4.1.2 Reimbursement Process 4.1.3 Overview of Insurance Providers 4.1.4 Patient Share in Healthcare Spending 4.1.5 Drug Price Change 4.1.6 Pricing Policies 4.2 Regulatory Landscape 4.2.1 Overview of Regulatory Agencies 4.2.2 New Drug Approval Procedure for Pharmaceutical Products 4.2.3 Market Authorization Procedure for Medical Devices 4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

4.2.5 Licensing Process for Pharmaceutical Exports and Imports 4.2.6 Intellectual Property Rights 4.2.7 Clinical Trial Regulations 4.2.8 Pharmaceutical Advertising Regulations 4.2.9 Pharmacy Regulations 4.2.10 Labeling and Packaging Regulations 5 Country Analysis 5.1 Political Environment 5.1.1 Political Structure 5.1.2 Analysis of the Current Political Environment 5.1.3 Healthcare Policy Initiatives 5.2 Economic Landscape 5.3 Economic Indicators 5.3.1 Gross Domestic Product 5.3.2 National Income per Capita 5.3.3 Inflation 5.3.4 Currency Exchange Rate 5.3.5 Foreign Direct Investment 5.3.6 Foreign Exchange Reserves 5.3.7 Trade Balance 5.3.8 Government Structural Balance 5.3.9 General Government Gross Debt 5.3.10 Major Industries 5.4 Demographics 5.4.1 Population 5.4.2 Education and Literacy 5.4.3 Employment 5.4.4 Disease Burden 5.5 Healthcare Infrastructure 5.5.1 Healthcare Facilities 5.5.2 Healthcare Parameters 5.5.3 Environmental Health

5.5.4 Healthcare Personnel 5.6 Healthcare Expenditure 5.6.1 Overview 5.6.2 Components of Healthcare Spending 5.6.3 Public and Private Sector Share 5.6.4 Spending in Pharmaceutical R&D 5.7 Trade Associations 5.7.1 Indian Pharmaceutical Association 5.7.2 Indian Drug Manufacturer’s Association 5.7.3 Organization of Pharmaceutical Producers of India 5.7.4 Indian Pharmacy Graduates Association 5.8 Trade Fairs 6 Opportunities and Challenges 6.1 Opportunities 6.2 Challenges 7 Appendix 7.1 Abbreviations 7.2 Bibliography 7.3 Research Methodology 7.3.1 Coverage 7.3.2 Secondary Research 7.3.3 Forecasts 7.3.4 Expert Panel 7.4 Disclaimer 1.1 List of Tables Table 1: Pharmaceutical Market, India, Revenue ($bn), 2008-2014 Table 2: Pharmaceutical Market, India, Revenue Forecast ($bn), 2014-2020 Table 3: Pharmaceutical Market, India, Exports and Imports ($bn), 2008-2013 Table 4: Biotechnology Market, India, Market Segments of Bio-technology Industry, Share (%), 2015 Table 5: Major Therapeutic Areas, India, Turnover ($m), 2010 Table 6: Dr. Reddy’s, Global, Major Products, 2014

Table 7: Dr Reddy’s, Global, Late-Stage Pipeline, 2015 Table 8: Medical Device Market, India, Revenue ($bn), 2008-2014 Table 9: Medical Device Market, India, Revenue Forecast ($bn), 2015-2020 Table 10: Medical Device Market, India, Revenue by Segment, 2014 Table 11: Medical Device Market, India, Ophthalmic Devices Market ($m), 2008-2014 Table 12: Medical Device Market, India, Ophthalmic Devices Market, Market Share for Major Players (%), 2012 Table 13: Medical Device Market, India, IVD Market ($bn), 2008-2014 Table 14: Medical Device Market, India, IVD Market, Market Share for Major Players (%), 2012 Table 15: Medical Device Market, India, Orthopedic Device Market ($bn), 2008-2014 Table 16: Medical Device Market, India, Orthopedic Device Market, Market Share for Major Players (%), 2012 Table 17: Medical device market, India, Wound Care Management Market ($bn), 2008-2014 Table 18: Medical Device Market, India, Wound Care Management Market, Market Share for Major Players (%), 2012 Table 19: Medical Device Market, India, Cardiovascular Device Market ($bn), 2008-2014 Table 20: Medical Device Market, India, Cardiovascular Device Market, Market Share for Major Players (%), 2012 Table 21: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2008-2014 Table 22: Medical Device Market, India, Diagnostic Market, Revenue ($bn), 2014-2020 Table 23: Major Public Insurance Schemes, India, 2013 Table 24: Insured Population, India, Share ($bn), 2014 Table 25: Healthcare Spending, India, Out-of-Pocket Expenditure (% of Private Expenditure on Health), 20082013 Table 26: Market Access, India, Drug Price Change (%), 2008-2014 Table 27: Specific Requirements, New Drug Application, India, 2015 Table 28: Market Access, India, Schedule of Patent Fees, 2014 Table 29: Market Access, India, Schedule of Trademark Fees, 2014 Table 30: Specific Requirements, Clinical Trial Approval, India, 2011 Table 31: Economic Indicators, India, GDP per Capita ($), 2008-2014 Table 32: Economic Indicators, India, GDP per Capita Forecast ($), 2015-2020 Table 33: Economic Indicators, India, GDP Annual Growth (%), 2008-2014 Table 34: Economic Indicators, India, GDP Annual Growth Forecast (%), 2015-2020 Table 35: Economic Indicators, India, National Income per Capita ($), 2008-2014 Table 36: Economic Indicators, India, Average Consumer Price Index Forecast, 2008-2014

Table 37: Economic Indicators, India, Average Consumer Price Index Forecast, 2015-2020 Table 38: Economic Indicators, India, Average Consumer Price Annual Change (%), 2008-2014 Table 39: Economic Indicators, India, Currency Exchange Rate (INR/$), 2008-2014 Table 40: Economic Indicators, India, FDI ($bn), 2008-2014 Table 41: Economic Indicators, India, Foreign Exchange Reserves ($bn), 2008-2014 Table 42: Economic Indicators, India, Imports of Goods and Services ($bn), 2008-2014 Table 43: Economic Indicators, India, Exports of Goods and Services ($bn), 2008-2014 Table 44: Economic Indicators, India, Government Structural Balance ($bn), 2008-2014 Table 45: Economic Indicators, India, General Government Gross Debt (% of GDP), 2008-2014 Table 46: Economic Indicators, India, General Government Gross Debt Forecast (% of GDP), 2015-2020 Table 47: Economic Indicators, India, Major Industries, National income by Industry ($bn), 2013 Table 48: Demographics, India, Population (billion), 2008-2014 Table 49: Demographics, India, Population Forecast (billion), 2015-2020 Table 50: Demographics, India, Urban-Rural Population (%), 2008-2014 Table 51: Demographics, India, Population Distribution by Age Group (%), 2008-2014 Table 52: Demographics, India, Population Distribution by Age Group Forecast (%), 2015-2020 Table 53: Demographics, India, Births (per 1,000 Population), 2008-2014 Table 54: Demographics, India, Mortality (per 1,000 Population), 2008-2014 Table 55: Demographics, India, Major Causes of Mortality (%), 2012 Table 56: Demographics, India, Children